» Articles » PMID: 15207348

Presenilin 1 Familial Alzheimer's Disease Mutation Leads to Defective Associative Learning and Impaired Adult Neurogenesis

Overview
Journal Neuroscience
Specialty Neurology
Date 2004 Jun 23
PMID 15207348
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease is a learning and memory disorder pathologically characterized by the deposition of beta-amyloid plaques and loss of neurons and synapses in affected areas of the brain. Mutations in presenilin 1 (PS1) lead to the most aggressive form of familial Alzheimer's disease (FAD), and are associated with accelerated plaque deposition. However, since the function of PS1 is pleiotropic, we reasoned that the FAD mutations may alter multiple PS1-mediated pathways, and the combination of which may account for the early onset nature of the disease phenotype. Using the PS1M146V knockin mice in which the M146V mutation was incorporated into the endogenous mouse PS1 gene, we report here that the FAD mutation results in impaired hippocampus-dependent associative learning, as measured by a contextual fear conditioning paradigm, at 3 months of age. This is correlated with reduced adult neurogenesis in the dentate gyrus. However, short-term and long-term synaptic plasticity in both area CA1 and dentate gyrus are not affected. Our results suggest that impaired adult neurogenesis may contribute to the memory deficit associated with FAD.

Citing Articles

Quantification and correlation of amyloid-β plaque load, glial activation, GABAergic interneuron numbers, and cognitive decline in the young TgF344-AD rat model of Alzheimer's disease.

Futacsi A, Rusznak K, Szarka G, Volgyi B, Wiborg O, Czeh B Front Aging Neurosci. 2025; 17:1542229.

PMID: 40013092 PMC: 11860898. DOI: 10.3389/fnagi.2025.1542229.


The relationship between adult hippocampal neurogenesis and cognitive impairment in Alzheimer's disease.

Geigenmuller J, Tari A, Wisloff U, Walker T Alzheimers Dement. 2024; 20(10):7369-7383.

PMID: 39166771 PMC: 11485317. DOI: 10.1002/alz.14179.


Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.

Haniff Z, Bocharova M, Mantingh T, Rucker J, Velayudhan L, Taylor D Pharmacol Ther. 2024; 258:108641.

PMID: 38583670 PMC: 11847495. DOI: 10.1016/j.pharmthera.2024.108641.


Cytokine expression patterns predict suppression of vulnerable neural circuits in a mouse model of Alzheimer's disease.

Chan D, Kim C, Kang R, Kuhn M, Beidler L, Zhang N bioRxiv. 2024; .

PMID: 38559177 PMC: 10979954. DOI: 10.1101/2024.03.17.585383.


Critical thinking of Alzheimer's transgenic mouse model: current research and future perspective.

Li X, Quan M, Wei Y, Wang W, Xu L, Wang Q Sci China Life Sci. 2023; 66(12):2711-2754.

PMID: 37480469 DOI: 10.1007/s11427-022-2357-x.